Most Retirees Choose JEPI, but This 4.8% Yield Outperforms
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
Which Emergency Fund Length For Freelancers
Freelancers learn how to determine an appropriate emergency fund length given variable workloads, invoicing cycles, and income gaps.
22,516 articles
Energy Transfer's Units Surged in January: Key Takeaways
January brought a standout move in midstream equities as energy transfer's units surged. This in-depth look explains ...
Ethereum Firm Sharplink and Solana Boost Russell Inclusion
A new wave of crypto treasury firms, including ethereum firm sharplink and Solana-focused treasuries, could land in R...
The 10-Year Yield That Could Break VNQ in 2026
Vanguard Real Estate ETF faces a crucial test as the 10-year yield that drives REIT valuations hovers near 4.6%, pote...
Stock Down Investor Slashes KBR Stake as Backlog Tops
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
That Doubled 2026 Caught: Oil ETF in Supply, Capacity Split
The oil ETF that doubled in 2026 is navigating a renewed tug of war between supply shocks and capacity restoration. H...
Invesco Aerospace Defense U.S.: PPA vs JETS in 2026
Can a defense-focused ETF outperform a jet-fueled recovery play in 2026? This deep dive examines PPA and JETS, weighi...
Stepan (SCL) 2025 Earnings: Key Takeaways for Investors
Stepan (SCL) investors are focused on 2025 earnings drivers, margins, and cash flow. This guide breaks down the key c...
Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
ETFs Paying Yields While Investors Chase the S&P 500
With U.S. stocks marching higher, a quartet of ETFS paying yields while diversifies income and exposure beyond the S&...
Lucid Group Stock Going: A Practical Guide for Investors
Investors are watching Lucid Group stock going through a period of volatility as the company navigates ramp challenge...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status